Addressing the Real-World Challenges of Immunoresistance to Botulinum Neurotoxin A in Aesthetic Practice: Insights and Recommendations from a Panel Discussion in Hong Kong
With increasing off-label aesthetic indications using higher botulinum neurotoxin A (BoNT-A) doses and individuals starting treatment at a younger age, particularly in Asia, there is a greater risk of developing immunoresistance to BoNT-A. This warrants more in-depth discussions by aesthetic practit...
Main Authors: | Wilson W. S. Ho, Lisa Chan, Niamh Corduff, Wang-Tak Lau, Michael U. Martin, Clifton Ming Tay, Sandy Wang, Raymond Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/15/7/456 |
Similar Items
-
Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity
by: Michael Uwe Martin, et al.
Published: (2024-02-01) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
by: Bernard Poulain, et al.
Published: (2019-01-01) -
Zebrafish Sensitivity to Botulinum Neurotoxins
by: Kamalakar Chatla, et al.
Published: (2016-05-01) -
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
by: Michael W. Peck, et al.
Published: (2017-01-01) -
Antipruritic Effects of Botulinum Neurotoxins
by: Parisa Gazerani
Published: (2018-03-01)